List of Excipients in API granisetron hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing granisetron hydrochloride
Detailed excipient profiles for granisetron hydrochloride
Excipient focus: ANHYDROUS CITRIC ACID
granisetron hydrochloride drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | granisetron hydrochloride | 0143-9744 |
| Mylan Institutional LLC | granisetron hydrochloride | 67457-861 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BENZYL ALCOHOL
granisetron hydrochloride drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | granisetron hydrochloride | 0143-9744 |
| Akorn | granisetron hydrochloride | 17478-546 |
| Yung Shin Pharmaceutical Inc Co Ltd | granisetron hydrochloride | 63126-332 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing BENZYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
granisetron hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
granisetron hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
granisetron hydrochloride drug variants containing CITRIC ACID MONOHYDRATE
granisetron hydrochloride drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: HYDROCHLORIC ACID
granisetron hydrochloride drug variants containing HYDROCHLORIC ACID
granisetron hydrochloride drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYPROMELLOSE
granisetron hydrochloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | granisetron hydrochloride | 51991-735 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
granisetron hydrochloride drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | granisetron hydrochloride | 16714-221 |
| OrchidPharma Inc | granisetron hydrochloride | 42043-390 |
| Bionpharma Inc | granisetron hydrochloride | 69452-350 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
granisetron hydrochloride drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | granisetron hydrochloride | 0054-0143 |
| Natco Pharma Limited | granisetron hydrochloride | 63850-0005 |
| Ascend Laboratories LLC | granisetron hydrochloride | 67877-184 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
granisetron hydrochloride drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | granisetron hydrochloride | 0054-0143 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
granisetron hydrochloride drug variants containing LACTOSE MONOHYDRATE
granisetron hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
granisetron hydrochloride drug variants containing MAGNESIUM STEARATE
granisetron hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYLPARABEN
granisetron hydrochloride drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| AuroMedics Pharma LLC | granisetron hydrochloride | 55150-175 |
| WOCKHARDT LIMITED | granisetron hydrochloride | 55648-661 |
| Wockhardt USA LLC | granisetron hydrochloride | 64679-841 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing METHYLPARABEN
Excipient focus: PHENOL
granisetron hydrochloride drug variants containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | granisetron hydrochloride | 63323-319 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing PHENOL
Excipient focus: POLYETHYLENE GLYCOL
granisetron hydrochloride drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Natco Pharma Limited | granisetron hydrochloride | 63850-0005 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 4000
granisetron hydrochloride drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | granisetron hydrochloride | 51991-735 |
| Ascend Laboratories LLC | granisetron hydrochloride | 67877-184 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYSORBATE 80
granisetron hydrochloride drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | granisetron hydrochloride | 51991-735 |
| Natco Pharma Limited | granisetron hydrochloride | 63850-0005 |
| Ascend Laboratories LLC | granisetron hydrochloride | 67877-184 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing POLYSORBATE 80
Excipient focus: PROPYLPARABEN
granisetron hydrochloride drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| AuroMedics Pharma LLC | granisetron hydrochloride | 55150-175 |
| WOCKHARDT LIMITED | granisetron hydrochloride | 55648-661 |
| Wockhardt USA LLC | granisetron hydrochloride | 64679-841 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM CHLORIDE
granisetron hydrochloride drug variants containing SODIUM CHLORIDE
granisetron hydrochloride drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM CITRATE
granisetron hydrochloride drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | granisetron hydrochloride | 63323-319 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
granisetron hydrochloride drug variants containing SODIUM HYDROXIDE
granisetron hydrochloride drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
granisetron hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
granisetron hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: TITANIUM DIOXIDE
granisetron hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | granisetron hydrochloride | 51991-735 |
| Natco Pharma Limited | granisetron hydrochloride | 63850-0005 |
| Ascend Laboratories LLC | granisetron hydrochloride | 67877-184 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
granisetron hydrochloride drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | granisetron hydrochloride | 17478-546 |
| Akorn | granisetron hydrochloride | 17478-547 |
| >Company | >Ingredient | >NDC |
granisetron hydrochloride drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
granisetron hydrochloride drug variants containing WATER
granisetron hydrochloride drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
